Found 250 Results
Page 8 of 13

Patents


Patents The PharmaJet Stratis® and Tropis® Needle-free Injection Systems are covered under following US and international patents: US Patent #7,699,802 Patent #7,618,393 Patent #8,529,500 Patent #9,333,300 Patent #9,408,972 (Stratis only) Patent #9,345,642 (Stratis only) Patent #9,700,675 (Tropis only) Patent #9,433,735 (Tropis only) International Patent # PI0520281-7 (Brazil) Patent #46.847 (Chile) Patent #ZL 200580049989.4 (China) Patent...

January 7, 2022

About


About PharmaJet PharmaJet is a commercial stage MedTech Company with US and International distribution. PharmaJet partners with pharmaceutical companies to improve their injectable products PharmaJet’s Needle-free Systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and a proven path to commercialization. They are also safe, fast, and easy-to-use. The PharmaJet Tropis® device for...

PharmaJet partner Zydus Cadila announces COVID-19 vaccine expansion plan to multiple countries with Korean firm


GOLDEN, Colo. — January 4, 2022 – PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila, is partnering with Enzychem Lifesciences to manufacture their COVID-19 plasmid DNA vaccine (ZyCoV-D®) in Korea. The plan is to manufacture 80+ million doses of the ZyCoV-D vaccine, which was recently granted emergency use approval (EUA) by India’s national regulatory agency for those aged 12 years and above. The vaccine will be manufactured in Korea and exported to several lower-middle income countries in Latin America and Asian New Southern Policy member countries. It is exclusively delivered by the PharmaJet Tropis® Needle-free Injection System.

Tags: , , ,

January 4, 2022

PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next generation DNA-based COVID-19 vaccine candidates


GOLDEN, Colo. — December 14, 2021 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that one of its pharmaceutical partners, Nykode Therapeutics (formerly Vaccibody) has begun a phase 1/2 clinical trial to specifically address emerging SARS-CoV-2 variants. The DNA-based vaccines will be delivered intramuscularly in the clinical trial exclusively using the PharmaJet Stratis® Needle-free Injection System.

Tags: , , ,

December 14, 2021

Press Coverage


Press Coverage All Tags COVID-19  (14) DNA  (2) Flu  (6) Gennova  (2) HIV  (1) mRNA  (3) Nucleic Acid  (2) Other  (2) Polio  (12) Stratis  (16) Tropis  (28) Tropis/Stratis  (9) Reset No post found

October 28, 2025

Tropis


Tropis® ID The Tropis Needle-free Injection System delivers a precise 0.1 mL intradermal dose to help optimize your injectable product. Completely needle-free Reduces injection hesitancy Minimal training required Download User Guide Product Features Intradermal delivery Fixed dose 0.1 mL 25% faster workflow compared with Mantoux technique Minimal training required Compatible with most injectables Spring-powered Delivers...

December 2, 2021

Publications


Publications All Categories Clinical Studies  (36) Pre-Clinical Studies  (23) All Tags Adjuvants  (1) ANDV  (3) Arboviruses  (10) Atherosclerosis  (1) Cancer  (3) Clinical  (2) COVID-19  (10) Cow  (3) Dengue  (5) DNA  (24) DOBV  (1) Equine Influenza  (1) Hamster  (2) Hantaviruses  (5) Hepatitis B  (1) HIV  (1) HNTV  (1) Horse  (1) HPV  (1) HTNV  (1) Improved Performance  (14) Inactivated  (14) Infectious Diseases  (1) Influenza  (5) Live Attenuated  (7) Lymphoma  (1) Mice  (1) MMR  (3) Mouse  (2) mRNA  (2) Nanoparticle  (1) Non-Human  (1) Non-Human Primate  (10) Other Applications  (2) Other Viruses  (9) Pentavalent  (1) Phase 1  (6)...

October 28, 2025

News Releases


Company News All Tags Alzheimer’s  (1) Cancer  (7) COVID-19  (23) Disposable  (1) DNA  (40) Events  (13) Flu  (6) HIV  (1) HPV  (4) Infectious Diseases  (3) Melanoma  (4) MMR  (1) mRNA  (12) Nucleic Acid  (33) Other  (18) Polio  (27) Rabies  (4) Self-injector pen  (2) Stratis  (42) Subcutaneous  (2) Tropis  (66) Tropis/Stratis  (23) Tuberculosis  (2) VEEV  (3) Zika  (3) Zydus  (2) Reset Zika Virus vaccine shows significantly higher immune response with Needle-free delivery GOLDEN, Colo. — Jan. 9, 2018 — PharmaJet, the maker...

FAQs


Frequently Asked Questions What to Expect from the PharmaJet Needle-free Precision Delivery Systems How do they work?The spring-powered injectors deliver the vaccine or medicine by means of a narrow fluid stream, which penetrates the skin in about 1/10 of a second with a precise dose and depth. No external power source is required and there...

December 1, 2021

PharmaJet Named Asia’s Most Innovative Vaccine Delivery System at the Vaccine World Asia Congress 2021


GOLDEN, Colo. — November 30, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, has been named “Asia’s Most Innovative Vaccine Delivery System” at the Asia-Pacific Vaccine Excellence Awards 2021 (AVEA 2021). The award was accepted by Paul LaBarre, MS, MBA, Vice President, Global Business Development, PharmaJet, Inc.

Tags: , , , , ,

November 26, 2021

PharmaJet , WHO and BMGF conduct Somalia Polio Vaccination Campaign


GOLDEN, Colo. — October 21, 2021 – PharmaJet®the maker of innovative, needle-free injection technology, today announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia delivering inactivated polio vaccine to more than 110,000 children. The purpose of the campaign, funded in part by the Bill and Melinda Gates Foundation,…

November 1, 2021

PharmaJet Presents Needle-free delivery of COVID-19 Vaccines and Beyond at World Vaccine Congress – Europe


GOLDEN, Colo. — October 12, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and research results will be presented at the World Vaccine Congress – Europe on October 21. The presentation, entitled Needle-free Delivery: COVID-19 Vaccines and Beyond, is being presented by Erin K. Spiegel, PhD, Vice President,…

PharmaJet , WHO and BMGF conduct Somalia Polio Vaccination Campaign


GOLDEN, Colo. — October 21, 2021 – PharmaJet® the maker of innovative, needle-free injection technology, today announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia delivering inactivated polio vaccine to more than 110,000 children. The purpose of the campaign, funded in part by the Bill and Melinda Gates Foundation, using PharmaJet’s needle-free delivery product, supplied by the World Health Organization (WHO), is to ensure children under 5 who missed their routine immunization, receive their full regimen of inactivated polio vaccine.

Tags: ,

October 18, 2021

DNA Vaccines: The Next Stage in the Vaccine Revolution?


Over the last two years, there has been an unprecedented frenzy to develop new vaccines due to the COVID-19 pandemic, but DNA vaccines have rather stood in the shadow of their mRNA cousins.

Clinical OMICs

Tags: , , ,

October 10, 2021

At Bengaluru trial site, a peek into how Zydus Cadila’s needle-free Covid-19 vaccine for kids works


As India nears the rollout of ZyCoV-D, the world’s first DNA-based, needle-free Covid vaccine for individuals aged 12 years and above, one Bengaluru trial site gave the low-down on how the much talked about jab works.

Deccan Herald

Tags: ,

October 6, 2021

Home


Enhancing Immune Function Without Needles Partnering with pharmaceutical companies to improve their injectable products Speak with an Expert Needle-free is Making an Impact on Healthcare Partner Benefits Improves vaccines and therapeutics Proven regulatory pathway No drug reformulation Same fill/finish manufacturing process Commercially scaled Cost effective, reusable devices Healthcare Provider Benefits Consistent, reliable delivery Preferred by...

October 28, 2025

India’s DNA COVID vaccine is a world first – more are coming


The ZyCoV-D vaccine heralds a wave of DNA vaccines for various diseases that are undergoing clinical trials around the world.

Nature

Tags: , , ,

September 9, 2021

PharmaJet selected to deliver Scancell COVID-19 DNA Vaccine


GOLDEN, Colo. — September 14, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Scancell, has selected its devices to administer its two SARS-CoV-2 DNA vaccine candidates, SCOV1 and SCOV2. The vaccines will be exclusively administered using the PharmaJet Tropis® and PharmaJet Stratis® Needle-free Injection Systems.

Tags: , , , , ,

Page 8 of 13